Allogene Therapeutics, Inc. (ALLO) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Allogene Therapeutics, Inc., Fate Therapeutics, Inc..Total Return (%)
Allogene Therapeutics, Inc. (ALLO)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Allogene Therapeutics, Inc.
ALLO
Fate Therapeutics, Inc.
FATE
| Metric | Allogene Therapeutics, Inc. (ALLO) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.13 | $1.00 |
| Change | -0.04 (-3.42%) | -0.07 (-6.54%) |
| Market Cap | $0.26B | $0.11B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.81 | -0.60 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.78 | $5.92 |
| 52-Week Low | $1.06 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.27 | $-1.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALLO | -20.98% | -41.15% | -61.82% | -97.32% | -95.48% | -95.48% |
| FATE | 8.70% | -20.00% | -76.30% | -96.24% | -85.55% | -85.88% |